doc. Mgr. Martin Trbušek, Dr.

2013

• The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab

  PANOVSKÁ Anna SMOLEJ L. LYSÁK D. BRYCHTOVÁ Yvona ŠIMKOVIČ M. MOTYČKOVÁ M. VODÁREK P. LINDTNEROVÁ Michaela TRBUŠEK Martin MALČÍKOVÁ Jitka POSPÍŠILOVÁ Šárka MAYER Jiří DOUBEK Michael

  Article in Periodical

  European Journal of Haematology, year: 2013, volume: 90, edition: 6, DOI

• The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells

  NAVRKALOVÁ Veronika ŠEBEJOVÁ Ludmila ZEMANOVÁ Jana JAŠKOVÁ Zuzana TRBUŠEK Martin

  Article in Periodical

  Leukemia & Lymphoma, year: 2013, volume: 54, edition: 8, DOI

• TP53 aberrations in chronic lymphocytic leukemia

  TRBUŠEK Martin MALČÍKOVÁ Jitka

  Chapter of a book

  Advances in Chronic Lymphocytic Leukemia, edition: Vyd. 1, year: 2013, number of pages: 23 s.

• TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab

  ŠEBEJOVÁ Ludmila ŠRÁMEK Martin JAŠKOVÁ Zuzana BORSKÝ Marek POTĚŠIL David NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2013, type: Conference abstract

• TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab

  ŠEBEJOVÁ Ludmila ŠRÁMEK Martin JAŠKOVÁ Zuzana MALČÍKOVÁ Jitka NAVRKALOVÁ Veronika BORSKÝ Marek DOUBEK Michael MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Conference abstract

  Year: 2013, type: Conference abstract

2012

• "ULTRA-DEEP" sekvenování identifikuje TP53 mutace před jejich klonální selekcí léčbou u chronické lymfocytární leukémie

  STAŇO KOZUBÍK Kateřina MALČÍKOVÁ Jitka TRBUŠEK Martin TOM Nikola ŠMARDOVÁ Jana DOUBEK Michael BRYCHTOVÁ Yvona MAYER Jiří POSPÍŠILOVÁ Šárka TICHÝ Boris

  Conference abstract

  Year: 2012, type: Conference abstract

• Analýza mutací v genech pro mikroRNA u pacientů s chronickou lymfocytární leukémií.

  KMÍNKOVÁ Jana MRÁZ Marek NAVRKALOVÁ Veronika PAVLOVÁ Šárka PLEVOVÁ Karla TICHÝ Boris MALČÍKOVÁ Jitka ŠEBEJOVÁ Ludmila BENEŠ Vladimír RAUSCH T. BRYCHTOVÁ Yvona DOUBEK Michael TRBUŠEK Martin MAYER Jiří POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2012, type: Conference abstract

• Clonal selection of TP53 mutations in chronic lymphocytic leukaemia detected by ultra-deep pyrosequencing

  STAŇO KOZUBÍK Kateřina MALČÍKOVÁ Jitka TRBUŠEK Martin TOM Nikola DOUBEK Michael BRYCHTOVÁ Yvona ŠMARDOVÁ Jana MAYER Jiří POSPÍŠILOVÁ Šárka TICHÝ Boris

  Conference abstract

  Year: 2012, type: Conference abstract

• Deep sequencing identifies TP53 mutations before their clonal selection by therapy in chronic lymphocytic leukemia

  TRBUŠEK Martin STAŇO KOZUBÍK Kateřina MALČÍKOVÁ Jitka ŠMARDOVÁ Jana ŠEBEJOVÁ Ludmila DOUBEK Michael BRYCHTOVÁ Yvona SVITÁKOVÁ M. PAVLOVÁ Šárka MRÁZ Marek PLEVOVÁ Karla VRÁNOVÁ V. TOM Nikola MAYER Jiří POSPÍŠILOVÁ Šárka TICHÝ Boris

  Conference abstract

  Year: 2012, type: Conference abstract

• Defects of ATM gene involving mutation lead to complete elimination of ATM function in chronic lymphocytic leukemia

  NAVRKALOVÁ Veronika ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila KMÍNKOVÁ Jana KUBEŠOVÁ Blanka DOUBEK Michael BRYCHTOVÁ Yvona MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin

  Year: 2012, type: